Skip to main content
analogs of an actin toxin natural product with anti-cancer activity

Research Showcase - Allingham/Craig/Evans labs

A multidisciplinary study published in the high impact journal JACS from the Allingham, Craig and Evans labs identifies synthetic analogs of the filamentous actin severing toxin Mycalolide B that reduce the invasiveness of metastatic cancer cells. 


Cancer cell invasion and tumour metastasis are driven by the actin cytoskeleton

Actin severing activity of the macrolide toxin Mycalolide B has been retained in a simplified synthetic analog

New therapies targeting metastasis will be developed around delivery systems for the synthetic analogs targeting actin


Get the full story here: